US 6,310,040 B1 · Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs

Abstract

Disclosed is a method for promoting retinal neuronal survival in a mammal, wherein the neuronal cells are at risk of dying. The method comprises administering to the mammal an effective dose of at least one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; or a functional derivative of IGF-II.

Claims1

Dependent claims

A method for promoting the survival of photoreceptors in a mammal, said photoreceptors being at risk of dying, said method comprising administering to said mammal an effective dose of Insulin-like Growth Factor-I.

Dependencies are inferred from the claim text.

Facts

Application

07/963,329Filed 15 Oct 1992 · continuation in part

Priority

8 Nov 1991

Granted

30 Oct 2001

Term ends

Not estimatedThe source records don’t support an estimate.

Classification14 codes

A01N 57/20
Having phosphorus-to-carbon bonds: containing acyclic or cycloaliphatic radicals
A61P 25/02
Drugs for disorders of the nervous system: for peripheral neuropathies
A61P 27/02
Drugs for disorders of the senses: ophthalmic agents
C07F 9/301
Phosphinic acids [R2P]; Thiophosphinic acids ; [R2P ]: acyclic saturated acids which can have further substituents on alkyl

Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs

Life of this patent

Abstract

Claims1

Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs

Life of this patent

Abstract

Claims1